BLEEDING DISORDERS (PRIMARY HAEMOSTASIS) Flashcards

1
Q

What are the causes of thrombocytopenia?

A

Idiopathic Immune Thrombocytopenic Purpura (Auto-ITP). These Ab do NOT activate the platelets. Instead they opsonize them for clearance

Thrombotic Thrombocytopenic Purpura/ Haemolytic Uremic Syndrome (TTP/HUS)

Disseminated Intravascular Coagulation (DIC) (both primary and secondary)

Heparin induced thrombocytopenia (HIT)

Thrombocytopenia in pregnancy

  • Gestational Thrombocytopenia: physiologic adaptation of pregnancy, related to the increased plasma volume, pooling or consumption of platelets in the placenta, or other physiologic changes that occur in uncomplicated pregnancies
  • HELLP / Pre-eclampsia, Eclampsia

Hypersplenism

Haematological malignancies (e.g. MDS, Myelofibrosis, leukaemia leading to bone marrow failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the causes of abnormal platelet function?

A

Inherited disorders (rare):

  • Glanzmann’s thrombasthenia (2b-3a deficiency)
  • Bernard-Soulier Syndrome (1b deficiency)
  • Storage pool disease (deficiency in ADP in platelet granules)

Acquired disorders e.g. aspirin, renal failure

  • Renal failure causes uraemia: abnormal platelet function
  • Aspirin causes abnormal activation due to inhibition of TXA2 production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes of vessel wall disorders that lead to increased bleeding?

A

Hereditary vascular disorders

Acquired: Vit C deficiency (scurvy), high dose steroids, age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

[IDIOPATHIC IMMUNE THROMBOCYTOPENIC PURPURA (AUTO-ITP)]

Acute ITP

  • Peak age
  • Female: Male
  • Preceding infection
  • Inset
  • Platelet count
  • Duration
  • Spontaneous remission
A
  • Peak age: children (2- 6 y/o)
  • Female: Male –> 1:1
  • Preceding infection : common
  • onset: abrupt
  • Platelet count: <20 000
  • Duration: 2-6 weeks
  • Spontaneous remission: common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

[IDIOPATHIC IMMUNE THROMBOCYTOPENIC PURPURA (AUTO-ITP)]

Chronic ITP

  • Peak age
  • Female: Male
  • Preceding infection
  • Inset
  • Platelet count
  • Duration
  • Spontaneous remission
A
  • Peak age: Peak Age Children (2-6 y.o.) Adults (20-40 y.o.)
  • Female: Male –>3:1
  • Preceding infection : rare
  • onset: abrupt- indolent
  • Platelet count: <50 000
  • Duration: Long-term
  • Spontaneous remission: uncommon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

[IDIOPATHIC IMMUNE THROMBOCYTOPENIC PURPURA (AUTO-ITP)]

What is the presentation of ITP?

A
  • ITP patients usually will have severely low platelet count (<10)
  • However, bleeding risk of ITP is surprisingly LOW for someone with such low plt count
  • Suspect ITP in patient who has thrombocytopenia but otherwise asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

[IDIOPATHIC IMMUNE THROMBOCYTOPENIC PURPURA (AUTO-ITP)]

What is the management of ITP?

A

Platelet count >50,000: no symptoms, no treatment needed

Platelet count 20,000 – 50,000:

  • If not bleeding, no treatment needed
  • If bleeding, give steroids OR IVIG

Platelet count <20,000:

  • If not bleeding, give steroids
  • If bleeding, give steroids, IVIG AND hospitalize.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

[THROMBOTIC THROMBOCYTOPENIC PURPURA]

What is the definition of TTP?

A

MAHA + low platelets and no identifiable cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

[THROMBOTIC THROMBOCYTOPENIC PURPURA]

What are the features of TTP (FATRN)?

A
  • Fever
  • Anaemia (MAHA)
  • Thrombocytopenia
  • Renal Failure (AKI) – not as common
  • Neurological disturbances* – distinguishes TTP from HUS (TIA, Stroke, Altered mental status, Seizure etc)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

[HUS] What are the features of HUS (RAT)?

A
  • Renal Failure (AKI)* – distinguishes TTP from HUS
  • Anaemia (MAHA)
  • Thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

[HUS] How is HUS different from TTP?

A
  • Renal failure is common (since this is the 1’ location of infection by E Coli / Shigella)
  • Children more frequently affected (<5 YO)
  • HUS is a/w E. coli 0517 phenotype (aka Enterohaemorrhagic E Coli - EHEC) or Shigella (releases shiga-toxins). No neurological disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

[TTP] What are the causes of TTP?

A

Pathophysiology of idiopathic/congenital TTP
- ADAMTS 13 protein absent (congenital) or autoantibodies against ADAMTS 13 (hence may require immunosuppression as part of treatment)

Causes of Secondary TTP: mechanism not so clear

  • Drugs (eg: penicillin, clopidogrel)
  • BM transplant
  • SLE
  • Malignancy
  • Pregnancy
  • Infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

[TTP/ HUS] What are the investigations for TTP/ HUS?

A
  • FBC: Anaemia, thrombocytopenia
  • Peripheral blood film: RBC fragments (schistocytes)
  • Coagulation screen (PT/APTT), fibrinogen, D-dimer: normal in TTP (differentiate from DIC)
  • Urine and Electrolytes: look for renal dysfunction (esp. in HUS)
  • ADAMTS 13 level: turnover time takes too long. Hence as long as we suspect a TTP (aka MAHA, Low Plt, normal Coag Time)  we will immediately plasmapheresis to give ADAMTS13!

Others: LFT, LDH, Direct Coombs Test, Urinalysis, ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

[TTP] What is the management of TTP?

A

Daily plasma exchange (plasmapheresis)

  • Mortality with management is 10-30% (rather than >90%)
  • Exchange is better than plasma infusion (plasma contains healthy ADAMTS 13)
  • Average number of exchanges for remission was 15.8 (range 3-36)

Normally we will NOT want to transfuse platelets during plasmapheresis due to risk of further MAHA (since plasmapheresis takes ~4hrs)
- EXCEPTION: if patient has active bleeding (eg: subdural haemorrhage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

[Heparin induced thrombocytopenia] What are the clinical features of HIT?

A

Fall in platelets by more than 50%

Within 5-10 days after commencing heparin

Associated with high risk of thrombosis (both venous and arterial)

  • leading to amputation
  • Thrombotic Sequalae (especially if arterial): skin necrosis, limb gangrene, organ infarction

Bleeding is rare because the platelet count nadir typically does not drop below 20,000/microL. However, bleeding has been reported

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

[Heparin induced thrombocytopenia] How do you diagnose HIT?

A
  • We should do FBCs 7 days after giving heparin (both UF and LMWH) after giving heparin to make sure that platelets are not down trending. Dx when we observe a fall in plt by >50%

Or if a pt presents with thrombocytopenia, we screen for Anti Heparin-PF4 Ab

17
Q

[Heparin induced thrombocytopenia] How do you manage HIT?

A

Stop Heparin IMMEDIATELY

FULLY ANTICOAGULATE with something else (cannot use warfarin/heparin) before a major thrombosis occurs (eg: NAOCs)

  • no need to give Platelets!
18
Q

[VON WILLEBRAND DISEASE]

There are 3 types of vWD: type 1, type 2 and type3. vWD type 2 is the most common.

  • Types 1 and 2 are inherited as __________
  • Type 3 is inherited as __________

Type 1: _______________

  • VWF Ag <30%
  • Reduced Multimers

Type 2: _________________

  • VWF Ag <30%
  • VWF Function : Ag < 0.6
  • Large Multimers Absent
  • Type 2A: Defective Multimerization: impaired ___________
  • Type 2B: Increased binding of vWF to Gp1b: cleared from plasma (will also have low platelet count) –> Increased RIPA, Thrombocytopenia

Type 3: _____________

  • VWF Ag <30%
  • Absent Multimers
A

autosomal dominant;

autosomal recessive;

Partial quantitative deficiency (i.e. reduced amount of protein)

Qualitative deficiency (i.e. abnormal protein that does not work well);

tethering to endothelium;

Total quantitative deficiency (i.e. absent protein)

19
Q

[VON WILLEBRAND DISEASE] What are the investigations required?

A

Coagulation screen:

  • Important for ALL Types
  • Basic coagulation screen can be normal.
  • But VWF carries FVIII in circulation (protects against degradation) so FVIII may be low and APTT prolonged.

Von Willebrand Factor antigen levels:

  • low <30%: Important for Type 1, 3
  • 2 concordant results are required because levels increase with exercise/stress/needle phobia/combined contraceptive pill/ pregnancy
  • <30% is Von Willebrand disease, 30-50% is primary haemostatic disorder with low vWF as risk factor

Von Willebrand activity level: Important for Type 2

  • Ristocetin cofactor activity
  • Collagen binding assay

Multimer Analysis Important for All Types

  • Type 1: reduced multimers
  • Type 3: absent multimers
  • Type 2A and 2B: large multimers absent

Ristocetin Induced Platelet Agglutination (RIPA)
- Important for Type 2B

20
Q

What is the management of vWF disease?

A

Increase release of VWF with DDAVP (desmopressin)

  • Vasopressin derivative
  • 2-5 fold rise in VWF-VIII (VIII>vWF)
  • Releases endogenous stores - hence only useful in mild disorders
  • Antidiuretic effect; can lead to water retention
  • Not helpful in Type IIa: since vWF has decreased function
  • C/I in Type IIb: leads to severe thrombocytopenia!

Replace VWF with plasma derived viral-inactivated concentrates e.g haemate P

Promote haemostasis by using anti-fibrinolytic drugs e.g. tranexamic acid

  • Inhibits fibrinolysis
  • Widely distributed – crosses placenta
  • Low concentration in breast milk